News & Updates
Filter by Specialty:

Is liraglutide cardioprotective in T2D patients?
In individuals with type 2 diabetes (T2D), the glucagon-like peptide-1 receptor agonist (GLP1-RA) liraglutide appeared to yield a cardioprotective benefit, data from the secondary endpoint analysis of the LIRAFLAME* trial suggests.
Is liraglutide cardioprotective in T2D patients?
06 Oct 2021
Gestational diabetes bears increased hazard of microalbuminuria in third trimester
Among women with gestational diabetes mellitus, microalbuminuria may occur in the third trimester despite exposure to only a brief period of overt hyperglycaemia, a study has found.
Gestational diabetes bears increased hazard of microalbuminuria in third trimester
04 Oct 2021
Severe hypoglycaemia ups risk of adverse outcomes in older patients
Severe hypoglycaemia is a risk factor for hospitalization and mortality among older patients with diabetes, a study reports. The event may also serve as a marker of future cardiovascular events among those with pre-existing heart disease and obesity.
Severe hypoglycaemia ups risk of adverse outcomes in older patients
01 Oct 2021
Diabetes increases the risk of fracture among patients on kidney replacement therapy
Patients undergoing kidney replacement therapy appear to be at increased risk of developing a fracture in the presence of diabetes, a study has found.